Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors.
about
The cell cycle independence of HIV infections is not determined by known karyophilic viral elements.Foamy virus vectors for HIV gene therapyFoamy virus biology and its application for vector developmentGene therapy studies in a canine model of X-linked severe combined immunodeficiencyViral Genome Tethering to Host Cell Chromatin: Cause and ConsequencesIntravenous injection of a foamy virus vector to correct canine SCID-X1.Centrosomal latency of incoming foamy viruses in resting cells.Foamy virus vector-mediated gene correction of a mouse model of Wiskott-Aldrich syndrome.The foamy virus genome remains unintegrated in the nuclei of G1/S phase-arrested cells, and integrase is critical for preintegration complex transport into the nucleus.Large animal models of hematopoietic stem cell gene therapy.Foamy virus vector integration sites in normal human cellsHIV infection of non-dividing cells: a divisive problem.Foamy-virus-mediated gene transfer to canine repopulating cells.High-titer foamy virus vector transduction and integration sites of human CD34(+) cell-derived SCID-repopulating cells.Interactions of Prototype Foamy Virus Capsids with Host Cell Polo-Like Kinases Are Important for Efficient Viral DNA Integration.Regulatable gene expression systems for gene therapy applications: progress and future challenges.Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors.Gene therapy for pituitary tumors.Large animal models for foamy virus vector gene therapy.Foamy virus infection in primates.A novel competitive repopulation strategy to quantitate engraftment of ex vivo manipulated murine marrow cells in submyeloablated hosts.Replication in a superficial epithelial cell niche explains the lack of pathogenicity of primate foamy virus infectionsMutations in the amino terminus of foamy virus Gag disrupt morphology and infectivity but do not target assembly.Deoxynucleoside triphosphate incorporation mechanism of foamy virus (FV) reverse transcriptase: implications for cell tropism of FVLong-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency.Overnight transduction with foamyviral vectors restores the long-term repopulating activity of Fancc-/- stem cells.Production and purification of high-titer foamy virus vector for the treatment of leukocyte adhesion deficiency.Foamy virus vectors for gene transfer.Molecular biology of foamy viruses.Foamy virus: an available vector for gene transfer in neural cells and other nondividing cells.Early events in foamy virus-host interaction and intracellular traffickingPrototype foamy virus gag nuclear localization: a novel pathway among retrovirusesThe DNA-binding domain of the yeast Spt10p activator includes a zinc finger that is homologous to foamy virus integrase.Insulated Foamy Viral Vectors.A Hybrid Adenoviral Vector System Achieves Efficient Long-Term Gene Expression in the Liver via piggyBac Transposition.Retroviral vector interactions with hematopoietic cells.The fourth central polypurine tract guides the synthesis of prototype foamy virus plus-strand DNA.Experimental therapy of allogeneic solid tumors induced in athymic mice with suicide gene-transducing replication-competent foamy virus vectors.Adeno-associated virus vectors integrate at chromosome breakage sites.Foamy virus as a gene transfer vector to the central nervous system.
P2860
Q24816846-FF5D6BA9-0070-4F28-8463-C05E05AFB17AQ26859020-B4F8B3B2-AE97-4F2E-95CE-802A5280E418Q26864134-F9202585-EFEE-4E0D-97CE-3B34EC3CF75AQ27026069-5ECCF80E-F2B3-4F1C-9ECE-C458684CE1E2Q28079650-B940F03A-E8FD-4556-976A-8E92DE26FC26Q30409845-EA0DA96B-452F-477E-A70D-BA68870F1CD7Q33285871-3DF952F7-E2ED-4A0D-BF4D-649772B2DBC4Q33399020-59A29DC1-D3DF-4D7D-8B80-9857B0D32CE3Q33676449-3344E18A-ABA7-4615-BD9C-2D8593277DDEQ34039922-8B5727C3-538B-4C98-ADC8-8AF9BD1517E1Q34334976-F80E0725-379E-4D1B-A04A-59DD4B0BE1E3Q35127406-6020F5D0-20A8-4CAE-A446-E8D8FEA4A9FDQ35615750-381BEE0A-7CE5-4CE3-BCC5-6808A15EB0FCQ35635430-6D57FDF1-D690-4CF2-A1FA-3EBA1BFAFB10Q36118484-C0AECC43-48FE-46DC-B6B7-068ADF3B858EQ36157542-F0AC995C-CBB7-4FC4-B04C-2165AD00D6F8Q36362910-B4C09C0D-146C-4FFD-9D4E-5A58EAB290F5Q36386450-F38193A3-B8BB-429A-8EA2-0DB5D624AA0CQ36482767-808E0C4F-04CB-466C-A95C-D69F6A9C3860Q36548744-2F080815-7401-4728-9024-6225948144AFQ36640242-531CF0D6-3532-482D-9C30-BC0E878991B8Q36673204-5F3D65D2-B39B-4BE9-84EC-DD6F90657A29Q36748004-FCDE5951-328D-4F56-8CCE-9E6228CBB73DQ36845659-298EB11F-3484-4E71-AA50-7C89DDB58691Q36883869-502118C6-5038-4E53-A66B-73B49CA4FFF2Q37001945-3F94834D-3243-4274-BC57-F3C0110BD986Q37313583-6A90A64E-DBE9-46EA-82D9-A67428ADEAA0Q37594766-8210BE55-6620-413F-B9D8-57BE5FFEBFA8Q37743255-3D45D9B0-6F69-477E-B95B-CC5E6AF63771Q37802395-2DB620E8-C983-48CC-B01C-F8B29DBE6117Q38097291-BE99BE02-F8B1-42D1-A48B-3F9BD516C689Q38286110-87699163-3DBF-4032-8042-1210926F98C9Q38316773-6398E936-F8BC-4C3B-90ED-42BC89F2A6B2Q38808141-33B3D9E4-2E18-4D1D-8CDC-EA02B433030EQ38895305-1360230B-9525-4DF7-9DF1-83A063DCB213Q38927032-F8DDECFD-AD77-43B6-998A-B38157E6D850Q40337891-39CA2E05-02F4-43EE-BC0E-09E79118B1F5Q40419693-639E03E5-E1F2-40DD-9907-88CD54C32A7BQ40543184-8366F559-2D0B-4D5A-942C-62B929FD78E6Q41121819-821A7AFA-6777-45FF-B960-5D26A3BAC574
P2860
Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cell cycle requirements for tr ...... ovirus and lentivirus vectors.
@en
type
label
Cell cycle requirements for tr ...... ovirus and lentivirus vectors.
@en
prefLabel
Cell cycle requirements for tr ...... ovirus and lentivirus vectors.
@en
P2860
P1433
P1476
Cell cycle requirements for tr ...... ovirus and lentivirus vectors.
@en
P2093
Grant Trobridge
P2860
P304
P356
10.1128/JVI.78.5.2327-2335.2004
P407
P577
2004-03-01T00:00:00Z